Impulse Oscillometry Combined to FeNO in Relation to Asthma Control Among Preschool Children

Jiying Xiao1, Lingyue Liu1, Kamran Ali2

  • 1Department of Pulmonology, Hangzhou Children's Hospital, Hangzhou, Zhejiang, 310015, People's Republic of China.

PubMed

Insights

Fractional exhaled nitric oxide (FeNO) and impulse oscillometry (IOS) show significant differences in preschool children with asthma. FeNO is a strong predictor of asthma control, with IOS moderately improving its predictive value when combined.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Allergy and Immunology

Background:

  • Asthma control in preschool children remains a clinical challenge, necessitating improved diagnostic and predictive tools.
  • Impulse oscillometry (IOS) and fractional exhaled nitric oxide (FeNO) are non-invasive measures of airway function and inflammation, respectively.
  • Understanding their role in assessing asthma control in young children is crucial for effective management.

Purpose of the Study:

  • To analyze differences in IOS and FeNO metrics between controlled, uncontrolled asthma, and healthy preschool children.
  • To evaluate the predictive value of IOS and FeNO, individually and in combination, for identifying uncontrolled asthma in this age group.

Main Methods:

  • A cohort of 171 preschool children with asthma and 30 healthy controls were enrolled.
  • Asthma control was assessed after a 3-month follow-up, categorizing children into controlled (n=85) and uncontrolled (n=86) groups.
  • IOS and FeNO were measured at baseline, and receiver operating characteristic curve (AUROC) analysis was used to determine discriminative ability.

Main Results:

  • Significant differences in IOS parameters (R5, X5, R5-R20, Fres) were observed between controlled and uncontrolled asthma groups.
  • Fractional exhaled nitric oxide (FeNO) alone demonstrated a high discriminative ability (AUROC=0.88) for uncontrolled asthma.
  • Combining IOS metrics with FeNO further enhanced predictive power, with R5-R20+FeNO achieving the highest AUROC of 0.92.

Conclusions:

  • Both IOS and FeNO show significant differences related to asthma control in preschool children.
  • FeNO emerges as a primary predictor of asthma control, offering substantial discriminative value.
  • The integration of IOS metrics with FeNO provides a moderate increase in predictive capability for uncontrolled asthma.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
311
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240